Human Microbiome Market Size, Share, and Growth 2022-2028
Human Microbiome Market: Strategic Insights
Human Microbiome Market
-
CAGR (2021 - 2028)22.2% -
Market Size 2021
US$ 718.95 Million -
Market Size 2028
US$ 2,921.68 Million
Market Dynamics
GROWTH DRIVERS
- Demand for personalized medicine
- Advancements in microbiome research
FUTURE TRENDS
- Probiotic and prebiotic development
- Microbiome-based therapeutics
OPPORTUNITIES
- Growth in gut health awareness
- Increased funding in microbiome research
Key Players
- Rebiotix Inc
- Yakult Honsha Co Ltd
- Synthetic Biologics Inc
- DuPont
- MaaT Pharma
- Eligo Bioscience
- Merck Co Inc
- AOBiome LLC
- Kaleido
Regional Overview
- North America
- Europe
- Asia-Pacific
- South and Central America
- Middle East and Africa
Market Segmentation
Product
- Probiotics
- Foods
- Prebiotics
- Medical Foods
- Diagnostic Device
- Drugs and Supplements
Disease
- Obesity
- Diabetes
- Autoimmune Disorders
- Cancer
- Mental Disorders
Application
- Therapeutics and Diagnostics